A focus on obtaining regulatory approvals overseas and preparing IND applications for cardiomyocyte cell sheets, primarily in the United States and Europe, while expanding sales regions to Indonesia, Australia, Singapore, the Middle East and other markets. This also includes establishing overseas development bases and operating structures, and selecting alliance partners.